VIEMED HEALTHCARE, INC. (VMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 150M 300M 450M Q3 '21: 116.3M Q4 '21: 117.1M Q1 '22: 120.9M Q2 '22: 126.8M Q3 '22: 133.3M Q4 '22: 138.8M Q1 '23: 146.1M Q2 '23: 156.1M Q3 '23: 169.8M Q4 '23: 183M Q1 '24: 194M Q2 '24: 205.7M Q3 '24: 214.3M Q4 '24: 224.3M Q1 '25: 232.8M Q2 '25: 240.9M Q3 '25: 254.8M Q4 '25: 270.3M Q1 '26: 286.6M Q2 '26: 301.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 60M 120M 180M Q3 '21: 72.9M Q4 '21: 73.4M Q1 '22: 75.4M Q2 '22: 78.2M Q3 '22: 81.4M Q4 '22: 84.7M Q1 '23: 88.9M Q2 '23: 94.7M Q3 '23: 103.6M Q4 '23: 112.8M Q1 '24: 118.6M Q2 '24: 125.4M Q3 '24: 129.2M Q4 '24: 133.2M Q1 '25: 136.7M Q2 '25: 140.5M Q3 '25: 147.5M Q4 '25: 155.5M Q1 '26: 165M Q2 '26: 173.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

0 8M 16M 24M Q3 '21: 12.2M Q4 '21: 11.6M Q1 '22: 12.5M Q2 '22: 10.8M Q3 '22: 9.4M Q4 '22: 8.3M Q1 '23: 7.9M Q2 '23: 9.8M Q3 '23: 12.6M Q4 '23: 14.3M Q1 '24: 14.6M Q2 '24: 15.3M Q3 '24: 16.7M Q4 '24: 17.9M Q1 '25: 19.5M Q2 '25: 21M Q3 '25: 21M Q4 '25: 22.9M Q1 '26: 23.4M Q2 '26: 22.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 6M 12M 18M Q3 '21: 10.1M Q4 '21: 9.1M Q1 '22: 9.2M Q2 '22: 8.6M Q3 '22: 7.9M Q4 '22: 6.2M Q1 '23: 6M Q2 '23: 7.3M Q3 '23: 9.2M Q4 '23: 10.2M Q1 '24: 10.3M Q2 '24: 9.5M Q3 '24: 10.4M Q4 '24: 11.3M Q1 '25: 12.3M Q2 '25: 14M Q3 '25: 13.6M Q4 '25: 14.9M Q1 '26: 14.9M Q2 '26: 14.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 50M 100M 150M Q3 '21: 43.4M Q4 '21: 43.7M Q1 '22: 45.5M Q2 '22: 48.6M Q3 '22: 51.8M Q4 '22: 54.2M Q1 '23: 57.2M Q2 '23: 61.5M Q3 '23: 66.2M Q4 '23: 70.2M Q1 '24: 75.5M Q2 '24: 80.3M Q3 '24: 85.1M Q4 '24: 91.1M Q1 '25: 96.1M Q2 '25: 100.4M Q3 '25: 107.3M Q4 '25: 114.8M Q1 '26: 121.6M Q2 '26: 128.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 25M 50M 75M Q3 '21: 19.6M Q4 '21: 22.5M Q1 '22: 25M Q2 '22: 25.8M Q3 '22: 28.7M Q4 '22: 27.7M Q1 '23: 31.1M Q2 '23: 33.8M Q3 '23: 39.6M Q4 '23: 45.2M Q1 '24: 35.9M Q2 '24: 38.5M Q3 '24: 37.4M Q4 '24: 39.1M Q1 '25: 40.8M Q2 '25: 42.8M Q3 '25: 48.5M Q4 '25: 51.9M Q1 '26: 57.1M Q2 '26: 60.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-10M 0 10M 20M 30M Q3 '21: 1.7M Q4 '21: 2.8M Q1 '22: 3.1M Q2 '22: 90K Q3 '22: 4.7M Q4 '22: 4.8M Q1 '23: 7.5M Q2 '23: 11.1M Q3 '23: 15.9M Q4 '23: 19.1M Q1 '24: 8.5M Q2 '24: 8.2M Q3 '24: 3.5M Q4 '24: 1.3M Q1 '25: -6.5M Q2 '25: -3.6M Q3 '25: 5.4M Q4 '25: 11.9M Q1 '26: 25.9M Q2 '26: 29.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '20: 40.8M Q3 '20: 41.2M Q4 '20: 41M Q1 '21: 40.7M Q2 '21: 41M Q3 '21: 40.7M Q1 '22: 40.4M Q2 '22: 39.8M Q3 '22: 39.6M Q1 '23: 40M Q2 '23: 40.7M Q3 '23: 40.4M Q1 '24: 40.6M Q2 '24: 40.6M Q3 '24: 40.8M Q1 '25: 41.6M Q2 '25: 41.1M Q3 '25: 40.5M Q1 '26: 40.5M Q2 '26: 41.1M Q3 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.15 0.30 0.45 Q3 '21: 0.24 Q4 '21: 0.22 Q1 '22: 0.22 Q2 '22: 0.20 Q3 '22: 0.19 Q4 '22: 0.16 Q1 '23: 0.16 Q2 '23: 0.20 Q3 '23: 0.24 Q4 '23: 0.25 Q1 '24: 0.25 Q2 '24: 0.23 Q3 '24: 0.26 Q4 '24: 0.29 Q1 '25: 0.31 Q2 '25: 0.35 Q3 '25: 0.34 Q4 '25: 0.37 Q1 '26: 0.37 Q2 '26: 0.36 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.